{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:04:53Z","timestamp":1784905493133,"version":"3.55.0"},"reference-count":28,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Diabetic foot infections (DFI) drive most non-traumatic lower-limb amputations, and empirical regimens must track local microbiology, which is itself evolving under broad-spectrum antibiotic pressure. Methods: We retrospectively analysed all consecutive bacterial cultures from clinically infected diabetic foot lesions at a single Polish outpatient centre over 2021\u20132025. Isolates were identified by MALDI-TOF mass spectrometry and susceptibility was interpreted under contemporaneous EUCAST breakpoints (v12.0\u2013v15.0). Results: A total of 274 cultures yielded 443 isolates (polymicrobial index 1.62). Staphylococcus aureus remained the most common pathogen but fell from 55.0% to 38.9% of cultures, while Enterobacterales rose from 36.1% to 47.7% of all isolates. Proteus mirabilis and Streptococcus agalactiae emerged as major contributors, and Enterobacter hormaechei showed an apparent increase (the apparent rise in E. hormaechei reflects, at least in part, improved species-level identification rather than a true increase in incidence). Methicillin-resistant S. aureus was first documented in 2025 (6\/38; 15.8%). P. mirabilis showed deteriorating activity against trimethoprim\u2013sulfamethoxazole and ciprofloxacin, the first meropenem-resistant isolate appeared in 2025, and two carbapenem-non-susceptible Enterobacterales were also detected (2\/18 carbapenem-tested isolates in 2025; 11%). Conclusions: The DFI profile has shifted from an S. aureus-dominated Gram-positive ecology toward a polymicrobial, increasingly Gram-negative one, with the first documentation of MRSA (on reintroduction of routine oxacillin testing) and of carbapenem-non-susceptible Enterobacterales. Empirical policy for moderate-to-severe DFI should reliably cover Enterobacterales and methicillin-resistant Gram-positives while preserving carbapenems and glycopeptides through active stewardship.<\/jats:p>","DOI":"10.3390\/antibiotics15080723","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:53:26Z","timestamp":1784901206000},"page":"723","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Five-Year Evolution of the Microbiological Landscape of Diabetic Foot Infections (2021\u20132025): Rising Polymicrobial Gram-Negative Predominance and Emergence of Resistant Enterobacterales at a Single Large-Volume Outpatient Centre"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8288-1803","authenticated-orcid":false,"given":"Magdalena","family":"Maj","sequence":"first","affiliation":[{"name":"Dr Maj\u2014Diabetic Foot Prevention and Treatment Center, 62-002 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-8885","authenticated-orcid":false,"given":"Leszek","family":"Czupryniak","sequence":"additional","affiliation":[{"name":"Department of Diabetology and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e3687","DOI":"10.1002\/dmrr.3687","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","volume":"40","author":"Senneville","year":"2024","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Macdonald, K.E., Boeckh, S., Stacey, H.J., and Jones, J.D. (2021). The microbiology of diabetic foot infections: A meta-analysis. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06516-7"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Li, W., Sadeh, O., Chakraborty, J., Yang, E., Basu, P., and Kumar, P. (2025). Multifaceted antibiotic resistance in diabetic foot infections: A systematic review. Microorganisms, 13.","DOI":"10.3390\/microorganisms13102311"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Maity, S., Leton, N., Nayak, N., Jha, A., Anand, N., Thompson, K., Boothe, D., Cromer, A., Garcia, Y., and Al-Islam, A. (2024). A systematic review of diabetic foot infections: Pathogenesis, diagnosis, and management strategies. Front. Clin. Diabetes Healthc., 5.","DOI":"10.3389\/fcdhc.2024.1393309"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/1534734620953686","article-title":"Microbiota and its antibiotic susceptibility in diabetic foot infections: Observations from a Polish nonmetropolitan hospital, 2015\u20132016","volume":"21","author":"Michalek","year":"2022","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.33073\/pjm-2023-014","article-title":"The pathogen isolates in chronic wound infections in Poland","volume":"72","author":"Malka","year":"2023","journal-title":"Pol. J. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Boschetti, G., Sgarabotto, D., Meloni, M., Bruseghin, M., Whisstock, C., Marin, M., Ninkovic, S., Pinfi, M., and Brocco, E. (2021). Antimicrobial resistance patterns in diabetic foot infections, an epidemiological study in northeastern Italy. Antibiotics, 10.","DOI":"10.3390\/antibiotics10101241"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/1570161114666160625083742","article-title":"Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers among patients from southern Poland","volume":"14","author":"Pobiega","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sta\u0144kowska, M., Garbacz, K., Korzon-Burakowska, A., Bronk, M., Skotarczak, M., and Szyma\u0144ska-Dubowik, A. (2022). Microbiological, clinical and radiological aspects of diabetic foot ulcers infected with methicillin-resistant and -sensitive Staphylococcus aureus. Pathogens, 11.","DOI":"10.3390\/pathogens11060701"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1038\/s41598-025-33134-z","article-title":"Microbiological profile and antimicrobial resistance in diabetic foot infections: A cross-sectional study from a low- to middle-income country","volume":"16","author":"Arjan","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_12","first-page":"e95291","article-title":"Clinico-microbiological profile of diabetic foot ulcers: A retrospective study","volume":"17","author":"Das","year":"2025","journal-title":"Cureus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e00661-21","DOI":"10.1128\/Spectrum.00661-21","article-title":"Revisiting species identification within the Enterobacter cloacae complex by matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry","volume":"9","author":"Godmer","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e01049-22","DOI":"10.1128\/jcm.01049-22","article-title":"Automatic discrimination of species within the Enterobacter cloacae complex using matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry and supervised algorithms","volume":"61","author":"Candela","year":"2023","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2026, May 17). Breakpoint Tables for |Interpretation of MICs and Zone Diameters, Version 15.0, Valid from 1 January 2025. Available online: https:\/\/www.eucast.org."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e01129-19","DOI":"10.1128\/JCM.01129-19","article-title":"Point-counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute recommendations for reporting antimicrobial susceptibility results","volume":"57","author":"Kahlmeter","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.12968\/jowc.2023.32.Sup7.S19","article-title":"Clinical presentation of group B Streptococcus\u2013infected diabetic foot ulcers","volume":"32","author":"Waldman","year":"2023","journal-title":"J. Wound Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2024497","DOI":"10.4322\/acr.2024.497","article-title":"Emerging infection: Streptococcal toxic shock-like syndrome caused by group B Streptococcus, Streptococcus agalactiae","volume":"14","author":"Rajack","year":"2024","journal-title":"Autops. Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wang, J.-T., Chen, P.-C., Chang, S.-C., Shiau, Y.-R., Wang, H.-Y., Lai, J.-F., Huang, I.-W., Tan, M.-C., Lauderdale, T.-L.Y., and TSAR Hospitals (2014). Antimicrobial susceptibilities of Proteus mirabilis: A longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-486"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jaidane, N., Tilouche, L., Oueslati, S., Girlich, D., Azaiez, S., Jacquemin, A., Dortet, L., Naija, W., Trabelsi, A., and Naas, T. (2025). Clonal dissemination of NDM-producing Proteus mirabilis in a teaching hospital in Sousse, Tunisia. Pathogens, 14.","DOI":"10.3390\/pathogens14030298"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2147\/IDR.S398914","article-title":"Infection of diabetes foot caused by carbapenem-resistant Proteus penneri mediated by a novel plasmid containing blaNDM","volume":"16","author":"Wang","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11274-025-04362-2","article-title":"Whole genome sequencing\u2013based prediction of antimicrobial resistance evolution among the predominant bacterial pathogens of diabetic foot ulcer","volume":"41","author":"Vinod","year":"2025","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.ijid.2025.107843","article-title":"The increasing prevalence of Enterobacteriaceae as pathogens of diabetic foot osteomyelitis: A multicentre European cohort over two decades","volume":"154","author":"Murillo","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Co\u015fkun, B., Ayhan, M., Ulusoy, S., and Guner, R. (2024). Bacterial profile and antimicrobial resistance patterns of diabetic foot infections in a major research hospital of Turkey. Antibiotics, 13.","DOI":"10.3390\/antibiotics13070599"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Palomo, A.T., Pires, A.P.M., Matielo, M.F., de Athayde Soares, R., Pecego, C., Sacilotto, R., de Paula, A.I., Hosino, N., Gamba, C.M., and Fonseca, C.L. (2022). Microbiology of diabetic foot infections in a tertiary care hospital in S\u00e3o Paulo, Brazil. Antibiotics, 11.","DOI":"10.3390\/antibiotics11081125"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Soldevila-Boixader, L., Carrera-Salinas, A., Mur, I., Morata, L., Rivera, A., Bosch, J., Montero-Saez, A., Mart\u00ednez Castillejo, J., Benito, N., and Mart\u00ed, S. (2025). Exploring the microbiome of diabetic foot ulcers: A focus on cases with a clinical worse outcome. Antibiotics, 14.","DOI":"10.3390\/antibiotics14070724"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/723\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:12:57Z","timestamp":1784902377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antibiotics15080723"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15080723","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}